MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q2
hinzugefügt 31.07.2025
Land |
 Vereinigte Staaten |
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
694 M |
Marktkapitalisierung |
$ 840 M |
EBITDA (LTM) |
$ -79.8 M |
P/E (LTM) |
-4.65 |
P/S (LTM) |
1.27 |
EPS (LTM) |
-0.26 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Agilent Technologies
A
|
$ 118.25 | -1.27 % | $ 35.9 B | NYSE,SPB | USA |
 |
Burning Rock Biotech Limited
BNR
|
$ 22.5 | 9.44 % | $ 242 M | Nasdaq Global Market |  China |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
CareDx, Inc
CDNA
|
$ 22.42 | 27.6 % | $ 1.19 B | Nasdaq Global Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Co-Diagnostics
CODX
|
$ 1.46 | 2.82 % | $ 1.94 M | Nasdaq Capital Market | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 24.56 | -0.24 % | $ 682 M | Nasdaq Global Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Charles River Laboratories International
CRL
|
$ 176.94 | -2.0 % | $ 8.77 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Danaher Corporation
DHR
|
$ 193.78 | -2.18 % | $ 138 B | NYSE,SPB | USA |
 |
Interpace Biosciences
IDXG
|
$ 2.2 | - | $ 9.73 M | Nasdaq Global Select Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Illumina
ILMN
|
$ 132.72 | 0.35 % | $ 21.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Fulgent Genetics
FLGT
|
$ 16.13 | -0.25 % | $ 488 M | Nasdaq Global Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 28.63 | -1.58 % | $ 20 B | NYSE |  Niderland |
 |
Medpace Holdings
MEDP
|
$ 515.65 | -0.56 % | $ 14.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Guardant Health
GH
|
$ 85.7 | 0.99 % | $ 10.7 B | Nasdaq Global Select Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Anixa Biosciences
ANIX
|
$ 2.83 | -3.41 % | $ 91.8 K | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.2 | 4.27 % | $ 5.05 M | Nasdaq Capital Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
ICON Public Limited Company
ICLR
|
$ 115.58 | -0.79 % | $ 9.53 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
$ 266.36 | -0.14 % | $ 22.2 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 125.25 | 1.44 % | $ 5.86 B | Nasdaq Global Select Market | USA |
 |
Lantheus Holdings
LNTH
|
$ 83.92 | -0.02 % | $ 5.66 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 5.0 | -3.66 % | $ 463 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 8.16 | -5.99 % | $ 1.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.24 | -1.91 % | $ 2 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 191.46 | 0.02 % | $ 21.3 B | NYSE,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 5.17 | 0.58 % | $ 4.07 M | Nasdaq Global Select Market | USA |
 |
National Research Corporation
NRC
|
$ 17.62 | -1.23 % | $ 394 M | Nasdaq Global Select Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Natera
NTRA
|
$ 196.11 | -5.35 % | $ 19.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |